Today we’re excited to announce Tracer’s new partnership with AstraZeneca to bring ctDNA monitoring into clinical trials.
Tracer has been working for several years on developing better and better ways to quantify cancer in patients. Doing so has obvious benefits: evaluate whether a treatment works , determine when a patient is cancer-free, and monitor for recurrence.
We’re lucky to be living in a time when new technologies are being developed to attack this problem. At Tracer, we’ve been able to leverage advances in NGS, dPCR, computation, and robotics to develop cost-effective, sensitive, scalable solutions for measuring ctDNA-levels in the blood. Recently, we launched our tumor-informed dPCR test. Researchers running oncology clinical trials are using it to better understand disease.
NEW YORK, New York, December12, 2024 — Tracer Biotechnologies, a next-generation diagnostics company, todayannounced a multi-year project with AstraZeneca (LSE/STO/Nasdaq: AZN).
The agreement willenable AstraZeneca to use Tracer’s circulating tumor DNA (ctDNA) monitoringtechnology for clinical trials. Tracerhas developed a proprietary platform for tumor-informed ctDNA detection basedon digital polymerase chain reaction (PCR). Tracer’s platform optimizes ctDNAdetection, enabling cost-effective, precise, and scalable testing for patientsas an alternative to radiographic imaging.
“We are entering a newera of oncology where patients will no longer have to wait for costly andimprecise radiographic scans to assess treatment and disease progression,” saidMark Kaganovich, CEO of Tracer Biotechnologies. “We are proud to work with AstraZeneca to leverage frequent, precise,and cost-effective ctDNA measurement for minimal residual disease detection andtreatment response monitoring.”
About Tracer Biotechnologies
Tracer Biotechnologies is a next-generation diagnostics company. Tracer is the only ultrasensitive ctDNA assayfor Molecular Response surveillance. Combining tumor-informed personalizationwith dPCR allows Tracer to offer cost-effective assays for an unlimited numberof timepoints on a study. The Tracer assay is available for blood and urine.
